M. ÖZCAN, "PEMBROLIZUMAB İN PATIENTS WITH RELAPSED OR REFRACTORY PMBCL DATA FROM THE KEYNOTE-013 AND KEYTONE-170 STUDIES," ASH 2018 , 2018
ÖZCAN, M. 2018. PEMBROLIZUMAB İN PATIENTS WITH RELAPSED OR REFRACTORY PMBCL DATA FROM THE KEYNOTE-013 AND KEYTONE-170 STUDIES. ASH 2018 .
ÖZCAN, M., (2018). PEMBROLIZUMAB İN PATIENTS WITH RELAPSED OR REFRACTORY PMBCL DATA FROM THE KEYNOTE-013 AND KEYTONE-170 STUDIES . ASH 2018
ÖZCAN, MUHİT. "PEMBROLIZUMAB İN PATIENTS WITH RELAPSED OR REFRACTORY PMBCL DATA FROM THE KEYNOTE-013 AND KEYTONE-170 STUDIES," ASH 2018, 2018
ÖZCAN, MUHİT. "PEMBROLIZUMAB İN PATIENTS WITH RELAPSED OR REFRACTORY PMBCL DATA FROM THE KEYNOTE-013 AND KEYTONE-170 STUDIES." ASH 2018 , 2018
ÖZCAN, M. (2018) . "PEMBROLIZUMAB İN PATIENTS WITH RELAPSED OR REFRACTORY PMBCL DATA FROM THE KEYNOTE-013 AND KEYTONE-170 STUDIES." ASH 2018 .
@conferencepaper{conferencepaper, author={MUHİT ÖZCAN}, title={PEMBROLIZUMAB İN PATIENTS WITH RELAPSED OR REFRACTORY PMBCL DATA FROM THE KEYNOTE-013 AND KEYTONE-170 STUDIES}, congress name={ASH 2018}, city={}, country={}, year={2018}}